7Garantía y servicio

Garantía limitada de un año (sólo para Estados Unidos y Canadá)

Philips warrants that this product shall be free from defects in material, workmanship and assembly, under normal use, in accordance with the specifi cations and warnings, for a period of one year from the date of purchase.This warranty extends only to the original purchaser of the product, and is not transferable.To exercise your rights under this warranty, you must provide proof of purchase in the form of an original sales receipt that shows the product name and the date of purchase. For customer support or to obtain warranty service, please visit our website www.philips.com/welcome or Contact Philips Customer Care Center at:

1-888-PHILIPS (1-888-744-5477) IN U.S.A., Puerto Rico, or U.S. virgin islands. 1-800-

661-6162 (French speaking), 1-888-PHILIPS (1-888-744-5477) (English or Spanish speaking) in Canada.THERE ARE NO OTHER EXPRESS OR IMPLIED WARRANTIES. Philips liability

is limited to repair or, at its sole option, replacement of the product. Incidental, special and consequential damages are disclaimed where permitted by law.This warranty gives you specifi c legal rights.You may also have other rights that vary from state to state.

Banned Substance Declaration

This product comply with RoHs and Philips BSD (AR17-G04-5010-010) requirements.

32ES

Page 31
Image 31
Philips 10FF3CME, 42HF9385D, 8FF3CME, 10FF3CDW manual Garantía y servicio, Banned Substance Declaration

10FF3CME, 10FF3CDW, 8FF3CME, 42HF9385D specifications

Philips has established itself as a pioneer in the realm of healthcare technology, with innovations that elevate patient care and streamline medical processes. Among its noteworthy offerings are the Philips 8FF3CME and 10FF3CMI, two advanced ultrasound systems designed to meet the diverse needs of medical practitioners.

The Philips 8FF3CME is a versatile ultrasound probe designed for a variety of applications, including cardiology, obstetrics, and gynecology. Its compact design makes it suitable for both in-hospital and point-of-care environments. The 8FF3CME features advanced imaging technologies such as Crystal Clear Cycle and PureWave crystal technology. These enhancements ensure high-resolution images with superior clarity and detail, thereby facilitating accurate diagnostics. The probe operates at a frequency range of 3 to 8 MHz, providing flexibility for different imaging needs, while the lightweight and ergonomic design enhances portability and ease of handling.

On the other hand, the Philips 10FF3CMI is engineered with an emphasis on producing excellent imaging for adult and pediatric patients. This probe excels in applications like abdominal, vascular, and musculoskeletal imaging. With a frequency range of 4 to 13 MHz, the 10FF3CMI delivers exceptional image quality, allowing for meticulous examination and assessment. It is equipped with innovative imaging modes like 2D, Doppler, and 3D imaging, catering to a wide range of clinical settings and diagnostic requirements. Additionally, the probe's intuitive user interface and customizable settings enhance workflow efficiency and ease of use.

Both the 8FF3CME and 10FF3CMI come with Philips’ proprietary imaging software, which includes advanced post-processing capabilities that allow clinicians to optimize the quality of images after data acquisition. These systems are designed to integrate seamlessly with various ultrasound platforms and are compatible with the latest Philips ultrasound machines, enabling medical professionals to leverage the full potential of modern imaging technologies.

In summary, the Philips 8FF3CME and 10FF3CMI ultrasound probes are exemplary solutions for contemporary healthcare needs. With their innovative features, advanced imaging technologies, and user-friendly characteristics, these devices illuminate the path toward enhanced diagnostic precision and improved patient outcomes. As the medical field continues to evolve, Philips remains committed to delivering reliable and state-of-the-art healthcare solutions that empower clinicians and benefit patients alike.